2039 related articles for article (PubMed ID: 15087132)
21. Characterization of promoter elements involved in the down-regulation of topoisomerase IIalpha expression in a drug-resistant cell line.
Saxena D; Yiu GK; Ni X; Huang KC; Mantovani R; Jacquemin-Sablon AG; Ng SW
Gene; 2004 Nov; 342(1):145-55. PubMed ID: 15527974
[TBL] [Abstract][Full Text] [Related]
22. Sp1 and Sp3 transcription factors mediate trichostatin A-induced and basal expression of extracellular superoxide dismutase.
Zelko IN; Folz RJ
Free Radic Biol Med; 2004 Oct; 37(8):1256-71. PubMed ID: 15451065
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the infection-responsive bovine lactoferrin promoter.
Zheng J; Ather JL; Sonstegard TS; Kerr DE
Gene; 2005 Jun; 353(1):107-17. PubMed ID: 15935571
[TBL] [Abstract][Full Text] [Related]
24. Identification and analysis of the human neural polypyrimidine tract binding protein (nPTB) gene promoter region.
Romanelli MG; Lorenzi P; Morandi C
Gene; 2005 Aug; 356():11-8. PubMed ID: 16002244
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites.
Lok CN; Lang AJ; Mirski SE; Cole SP
Biochem J; 2002 Dec; 368(Pt 3):741-51. PubMed ID: 12197834
[TBL] [Abstract][Full Text] [Related]
26. Sp1 and Sp3 regulate basal transcription of the survivin gene.
Xu R; Zhang P; Huang J; Ge S; Lu J; Qian G
Biochem Biophys Res Commun; 2007 Apr; 356(1):286-92. PubMed ID: 17350596
[TBL] [Abstract][Full Text] [Related]
27. Identification of regulatory elements in the human adipose most abundant gene transcript-1 ( apM-1) promoter: role of SP1/SP3 and TNF-alpha as regulatory pathways.
Barth N; Langmann T; Schölmerich J; Schmitz G; Schäffler A
Diabetologia; 2002 Oct; 45(10):1425-33. PubMed ID: 12378384
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional regulation of mouse MARCKS promoter in immortalized hippocampal cells.
Wang L; Liu X; Lenox RH
Biochem Biophys Res Commun; 2002 Apr; 292(4):969-79. PubMed ID: 11944910
[TBL] [Abstract][Full Text] [Related]
29. Sp1 site is crucial for the mouse claudin-19 gene expression in the kidney cells.
Luk JM; Tong MK; Mok BW; Tam PC; Yeung WS; Lee KF
FEBS Lett; 2004 Dec; 578(3):251-6. PubMed ID: 15589828
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the promoter of 1A6/DRIM, a novel cancer-related gene and identification of its transcriptional activator.
Xing X; Du X; Lu Z; Ning T; Su X; Ke Y
Gene; 2005 Jan; 344():161-9. PubMed ID: 15656982
[TBL] [Abstract][Full Text] [Related]
31. Modulation of DNA topoisomerase II alpha promoter activity by members of the Sp (specificity protein) and NF-Y (nuclear factor Y) families of transcription factors.
Magan N; Szremska AP; Isaacs RJ; Stowell KM
Biochem J; 2003 Sep; 374(Pt 3):723-9. PubMed ID: 12769819
[TBL] [Abstract][Full Text] [Related]
32. Genomic organization and promoter analysis of the gene encoding the mouse chemoattractant-like receptor, CMKLR1.
Mårtensson UE; Owman C; Olde B
Gene; 2004 Mar; 328():167-76. PubMed ID: 15019996
[TBL] [Abstract][Full Text] [Related]
33. NKX2.1 regulates transcription of the gene for human bone morphogenetic protein-4 in lung epithelial cells.
Zhu NL; Li C; Xiao J; Minoo P
Gene; 2004 Feb; 327(1):25-36. PubMed ID: 14960358
[TBL] [Abstract][Full Text] [Related]
34. Cloning and characterization of the human beta2-glycoprotein I (beta2-GPI) gene promoter: roles of the atypical TATA box and hepatic nuclear factor-1alpha in regulating beta2-GPI promoter activity.
Wang HH; Chiang AN
Biochem J; 2004 Jun; 380(Pt 2):455-63. PubMed ID: 14984368
[TBL] [Abstract][Full Text] [Related]
35. Sp1/Sp3 and DNA-methylation contribute to basal transcriptional activation of human podoplanin in MG63 versus Saos-2 osteoblastic cells.
Hantusch B; Kalt R; Krieger S; Puri C; Kerjaschki D
BMC Mol Biol; 2007 Mar; 8():20. PubMed ID: 17343736
[TBL] [Abstract][Full Text] [Related]
36. The mouse chemerin receptor gene, mcmklr1, utilizes alternative promoters for transcription and is regulated by all-trans retinoic acid.
Mårtensson UE; Bristulf J; Owman C; Olde B
Gene; 2005 Apr; 350(1):65-77. PubMed ID: 15792532
[TBL] [Abstract][Full Text] [Related]
37. KLF5 is frequently deleted and down-regulated but rarely mutated in prostate cancer.
Chen C; Bhalala HV; Vessella RL; Dong JT
Prostate; 2003 May; 55(2):81-8. PubMed ID: 12661032
[TBL] [Abstract][Full Text] [Related]
38. Isolation and characterization of the human A-myb promoter: regulation by NF-Y and Sp1.
Facchinetti V; Lopa R; Spreafico F; Bolognese F; Mantovani R; Tavner F; Watson R; Introna M; Golay J
Oncogene; 2000 Aug; 19(34):3931-40. PubMed ID: 10951586
[TBL] [Abstract][Full Text] [Related]
39. Cyclic adenosine monophosphate (cAMP) stimulation of the kit ligand promoter in sertoli cells requires an Sp1-binding region, a canonical TATA box, and a cAMP-induced factor binding to an immediately downstream GC-rich element.
Grimaldi P; Capolunghi F; Geremia R; Rossi P
Biol Reprod; 2003 Dec; 69(6):1979-88. PubMed ID: 12904318
[TBL] [Abstract][Full Text] [Related]
40. Minimal and inducible regulation of tissue factor pathway inhibitor-2 in human gliomas.
Konduri SD; Osman FA; Rao CN; Srinivas H; Yanamandra N; Tasiou A; Dinh DH; Olivero WC; Gujrati M; Foster DC; Kisiel W; Kouraklis G; Rao JS
Oncogene; 2002 Jan; 21(6):921-8. PubMed ID: 11840337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
